Top Markets
Coin of the day
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Hisse Senetlerindeki Sıralama #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Hisse Fiyatı
$14.66
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$839.37M
Değişim (1 gün)
-2.67%
Değişim (1 yıl)
557.32%
Ülke
US
Ticaret Climb Bio, Inc. (CLYM)

Kategori

Climb Bio, Inc. (CLYM) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $15.73 - 2026-08-01

Gün sonu en düşük fiyat: $7.23 - 2024-09-01
Climb Bio, Inc. için hisse fiyatı geçmişi: 2024 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 113.43%
2025 31.56%
2024 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH